Related Experiment Video
Updated: May 27, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Neurostimulation: vagus nerve stimulation and beyond.
1Cleveland Clinic Epilepsy Center, OH, USA. kotagap@ccf.org
Seminars in Pediatric Neurology
|November 9, 2011
Summary
Vagus nerve stimulation (VNS) therapy is an FDA-approved, cost-effective neurostimulation option for medically intractable epilepsy. It is well-tolerated in all age groups, reducing medical costs and improving quality of life.
Area of Science:
- Neurology
- Biomedical Engineering
Background:
- Medically intractable epilepsy often necessitates alternative treatments when surgery is not an option.
- Neurostimulation offers a promising avenue for managing refractory epilepsy.
Purpose of the Study:
- To review the efficacy, tolerability, and cost-effectiveness of neurostimulation modalities for epilepsy.
- To discuss the current status and future potential of various neurostimulation techniques.
Main Methods:
- Review of existing literature on vagus nerve stimulation (VNS) therapy.
- Discussion of emerging neurostimulation techniques like deep brain stimulation (DBS) and responsive neurostimulation (RNS).
- Consideration of repetitive transcranial magnetic stimulation (rTMS) as a future option.
Main Results:
- Vagus nerve stimulation (VNS) therapy is FDA-approved and effective for epilepsy, with similar tolerability in children and adults.
- VNS therapy is cost-effective, reducing healthcare expenses and enhancing quality of life.
- Deep brain stimulation (DBS) and responsive neurostimulation (RNS) show efficacy but lack clinical approval.
- Repetitive transcranial magnetic stimulation (rTMS) is under development and shows future promise.
Conclusions:
- Vagus nerve stimulation (VNS) therapy is a valuable, established treatment for intractable epilepsy.
- Emerging neurostimulation technologies offer future therapeutic possibilities for epilepsy management.
